TuHURA Biosciences, Inc. secures $12.5 million in a private equity financing to advance cancer immunotherapy treatments, with an additional $3.0 million from warrant exercises.
Amount Raised
$12.5 Million
Round Type
Private Equity
TampaBiotechnologyHealthcareHealth CareTherapeuticsDescription
TuHURA Biosciences, Inc. has announced a definitive securities purchase agreement to issue $12.5 million in common stock through a private placement. The offering includes cash proceeds and warrant exercises totaling $3.0 million. The capital will help advance their pipeline of treatments to overcome resistance to cancer immunotherapy.
Quick answer
TuHURA Biosciences raised $12.5 Million in a Private Equity round, dated June 3, 2025. TuHURA Biosciences is based in Tampa, Florida, United States.
- How much did TuHURA Biosciences raise?
- TuHURA Biosciences raised $12.5 Million in a Private Equity round on June 3, 2025.
- What does TuHURA Biosciences do?
- Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to..
- Where is TuHURA Biosciences based and how big is it?
- TuHURA Biosciences is based in Tampa, Florida, United States. Fundz records about 23 employees.
- Who are the decision-makers at TuHURA Biosciences?
- Fundz holds 3 contacts at TuHURA Biosciences, including the Senior Research Scientist. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as TuHURA Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Pelthos Therapeutics raised $50M on July 1, 2025.
- Biofrontera raised $11M on June 27, 2025.
- NewcelX raised $1M (Seed) on June 27, 2025.
- Os Therapies raised $4.2M on June 23, 2025.
- Azora Therapeutics, Inc. (DE) raised $4.8M on May 2, 2025.
- Retension Pharmaceuticals raised $12M on April 22, 2025.
Who to call at TuHURA Biosciences, and when
A new round usually means TuHURA Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TuHURA Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TuHURA Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TuHURA Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TuHURA Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TuHURA Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.